Inflammatory Bowel Disease

News and commentary from the world of gastroenterology and hepatology

Conducting pre-op and post-op visits via telemedicine saved patients thousands of driving miles

Previous findings of more cardiac events in RA patients did not translate to IBD patients

Patients who used the service found it faster, easier, and more convenient than an outside lab

Higher rates of endoscopic remission and response with integrin receptor antagonist at 1 year

But the observational data may be too weak to impact practice on prophylaxis

Researchers call for evidence-based guidance, but expert advocates for surgeon's choice

Study findings open a window to other therapeutic options, expert says

Leading adalimumab brand still dominates market, but net spending plummeted

Investigational drug filgotinib demonstrated limited efficacy in DIVERSITY study

All drugs except one remained more expensive in the U.S.

Study also showed the monoclonal antibody was noninferior to ustekinumab

"Top down" vs "step up" therapy, FDA actions, rethinking placebos, and new tulisokibart data

Elevated risk of IBD for people exposed to environmental pollutants in the prior decade